4.6 Article

The Role of 7,8-Dihydroxyflavone in Preventing Dendrite Degeneration in Cortex After Moderate Traumatic Brain Injury

Journal

MOLECULAR NEUROBIOLOGY
Volume 53, Issue 3, Pages 1884-1895

Publisher

HUMANA PRESS INC
DOI: 10.1007/s12035-015-9128-z

Keywords

Traumatic brain injury; Dendrite; Degeneration; Brain-derived neurotrophic factor; 7,8-Dihydroxyflavone

Categories

Funding

  1. Indiana Spinal Cord & Brain Injury Research Grants
  2. Ralph W. and Grace M. Showalter Research Award
  3. Indiana University Biological Research Grant
  4. NIH [RR025761, 1R21NS072631-01A]

Ask authors/readers for more resources

Our previous research showed that traumatic brain injury (TBI) induced by controlled cortical impact (CCI) not only causes massive cell death, but also results in extensive dendrite degeneration in those spared neurons in the cortex. Cell death and dendrite degeneration in the cortex may contribute to persistent cognitive, sensory, and motor dysfunction. There is still no approach available to prevent cells from death and dendrites from degeneration following TBI. When we treated the animals with a small molecule, 7,8-dihydroxyflavone (DHF) that mimics the function of brain-derived neurotrophic factor (BDNF) through provoking TrkB activation reduced dendrite swellings in the cortex. DHF treatment also prevented dendritic spine loss after TBI. Functional analysis showed that DHF improved rotarod performance on the third day after surgery. These results suggest that although DHF treatment did not significantly reduced neuron death, it prevented dendrites from degenerating and protected dendritic spines against TBI insult. Consequently, DHF can partially improve the behavior outcomes after TBI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available